These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 994014)

  • 41. Effect of dosage regimen on natriuretic response to furosemide.
    Wilson TW; Falk KJ; Labelle JL; Nguyen KB
    Clin Pharmacol Ther; 1975 Aug; 18(2):165-9. PubMed ID: 1097152
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacodynamic assessment of diuretic efficacy and braking in a furosemide continuous infusion model.
    Adin D; Atkins C; Papich MG
    J Vet Cardiol; 2018 Apr; 20(2):92-101. PubMed ID: 29483040
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intermittent bolus injection versus continuous infusion of furosemide in normal adult greyhound dogs.
    Adin DB; Taylor AW; Hill RC; Scott KC; Martin FG
    J Vet Intern Med; 2003; 17(5):632-6. PubMed ID: 14529128
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of hematocrit variation on the urinary sodium excretion in normal and uremic dogs (author's transl)].
    Figueiredo JF; Stella SR; Gelman A; Ajzen H; Ramos OL
    Rev Bras Pesqui Med Biol; 1978 Oct; 11(4-5):213-21. PubMed ID: 725133
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Involvement of the renal kallikrein-kinin system in furosemide-induced natriuresis in rats.
    Fujita T; Kumagai Y; Ikeda Y; Inamura N; Iwata T; Ogino M; Majima M
    Jpn J Pharmacol; 2000 Oct; 84(2):133-9. PubMed ID: 11128035
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of the rate and composition of fluid replacement on the pharmacokinetics and pharmacodynamics of intravenous furosemide.
    Li T; Lee MG; Chiou WL
    J Pharmacokinet Biopharm; 1986 Oct; 14(5):495-509. PubMed ID: 3806372
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of probenecid on furosemide kinetics and natriuresis in man.
    Honari J; Blair AD; Cutler RE
    Clin Pharmacol Ther; 1977 Oct; 22(4):395-401. PubMed ID: 902452
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preliminary evaluation of furosemide-probenecid interaction in humans.
    Smith DE; Gee WL; Brater DC; Lin ET; Benet LZ
    J Pharm Sci; 1980 May; 69(5):571-5. PubMed ID: 7381747
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of intravenous infusion time on the pharmacokinetics and pharmacodynamics of the same total dose of furosemide.
    Lee MG; Li T; Chiou WL
    Biopharm Drug Dispos; 1986; 7(6):537-47. PubMed ID: 3828484
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Altered furosemide pharmacokinetics in chronic alcoholic liver disease with ascites contributes to diuretic resistance.
    Pinzani M; Daskalopoulos G; Laffi G; Gentilini P; Zipser RD
    Gastroenterology; 1987 Feb; 92(2):294-8. PubMed ID: 3466836
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronopharmacological study of furosemide in rats.
    Fujimura A; Ebihara A
    Life Sci; 1986 Mar; 38(13):1215-20. PubMed ID: 3457231
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Furosemide pharmacodynamics: effect of respiratory and acid-base disturbances.
    Babini R; du Souich P
    J Pharmacol Exp Ther; 1986 May; 237(2):623-8. PubMed ID: 3084762
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics and pharmacodynamics of furosemide after direct administration into the stomach or duodenum.
    Lee WI; Yoon WH; Shin WG; Song IS; Lee MG
    Biopharm Drug Dispos; 1997 Dec; 18(9):753-67. PubMed ID: 9429740
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prerenal azotemia: differentiation of hyperureagenesis from renal hypoperfusion using urinary urea nitrogen data.
    Sklar AH; Riesenberg LA; Ur Rehman A; Smith S; Rivera-Padilla H
    Int J Artif Organs; 1996 Mar; 19(3):164-9. PubMed ID: 8675360
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of probenecid and spironolactone on furosemide kinetics and dynamics in man.
    Homeida M; Roberts C; Branch RA
    Clin Pharmacol Ther; 1977 Oct; 22(4):402-9. PubMed ID: 902453
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The pharmacokinetics and pharmacodynamics of furosemide in anesthetized dogs with normal and experimentally decreased renal function.
    Miyazaki H; Hirai J; Taneike T
    Nihon Juigaku Zasshi; 1990 Apr; 52(2):265-73. PubMed ID: 2348592
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanism of impaired natriuretic response to furosemide during prolonged therapy.
    Loon NR; Wilcox CS; Unwin RJ
    Kidney Int; 1989 Oct; 36(4):682-9. PubMed ID: 2811065
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Natriuretic efficiency of frusemide as a consequence of drug input rate.
    Wakelkamp M; Alván G; Paintaud G
    Br J Clin Pharmacol; 1997 May; 43(5):481-91. PubMed ID: 9159563
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Natriuretic and sodium transport inhibitory activity in plasma of volume-expanded dogs.
    Buckalew VM; Nelson DB
    Kidney Int; 1974 Jan; 5(1):12-22. PubMed ID: 4813585
    [No Abstract]   [Full Text] [Related]  

  • 60. Defect in urinary acidification in nephrotic syndrome and its correction by furosemide.
    Rodriguez-Soriano J; Vallo A; Castillo G; Oliveros R
    Nephron; 1982; 32(4):308-13. PubMed ID: 7167208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.